Stock listing
PTCT Stock Price, News, Filings & Events — Ptc Therapeutics, Inc.
Selected listing: PTCT · NASDAQ · USD · US
This page tracks Ptc Therapeutics, Inc.'s PTCT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PTCT:NASDAQ. PTCT:NASDAQ is the stock-level entry point for investors researching Ptc Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ptc Therapeutics, Inc. is a public company traded on the American stock market under the ticker PTCT. The company has a market capitalization of approximately $6.37 billion. Ptc Therapeutics focuses on developing innovative therapies for patients with rare diseases.
- Ticker
- PTCT:NASDAQ
- Asset type
- Stock
- Market cap
- $5.83B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Ptc Therapeutics, Inc. PTCT:NASDAQ stock context
This page tracks Ptc Therapeutics, Inc.'s PTCT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PTCT:NASDAQ. PTCT:NASDAQ is the stock-level entry point for investors researching Ptc Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ptc Therapeutics, Inc. is a public company traded on the American stock market under the ticker PTCT. The company has a market capitalization of approximately $6.37 billion. Ptc Therapeutics focuses on developing innovative therapies for patients with rare diseases.
Latest news from Ptc Therapeutics, Inc.
PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and...
August 24, 2026
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
August 12, 2026
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
July 30, 2026
PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 16, 2026
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
June 15, 2026
Ptc Therapeutics, Inc. earnings calls
PTC Therapeutics, Inc. (PTCT) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call
February 19, 2026 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Ptc Therapeutics, Inc.
Ptc Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for PTCT:NASDAQ.
Ptc Therapeutics, Inc. company profile
View the public company page for Ptc Therapeutics, Inc. on 6ix.
Ptc Therapeutics, Inc. news
Read company news and market updates connected to Ptc Therapeutics, Inc..
Ptc Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Ptc Therapeutics, Inc..
Alternate listings
BH3:GETTEX
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
A1W0MW:LSX
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
A1W0MW:LS
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
PTCT:BOATS
US · USD
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
P91:BX
CH · CHF
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
BH3:DUS
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
BH3:FWB
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
BH3:HAM
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
BH3:MUN
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
BH3:SWB
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.
BH3:TRADEGATE
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is PTCT:NASDAQ.